Skip to main content

Natural Product Cancer Chemopreventive Agents

  • Chapter
Phytochemistry of Medicinal Plants

Part of the book series: Recent Advances in Phytochemistry ((RAPT,volume 29))

Abstract

At the current time, cancer claims the lives of approximately seven million people worldwide on an annual basis. In the United States alone, there are approximately one million new cases diagnosed each year, and approximately one-half million succumb to the disease. However, various cancer causes and methods of prevention are now obvious, and this knowledge should be brought to bear by members of an enlightened society. As an example, over 100,000 individuals in the United States die per year due to the manifestations of lung cancer, and a large percentage of these deaths could undoubtedly be negated by abolishing the smoking of cigarettes. In fact, the National Cancer Institute has devised a campaign in which the goal is to reduce the 1985 cancer mortality rate by 50% by the year 2000.1 The approach to achieving this goal is understandably comprehensive. In addition to primary prevention strategies (e. g., cessation of cigarette smoking, reduction of exposure to chemical carcinogens), elements such as early diagnosis, dietary modification, and cancer training programs will need to be emphasized.2

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Greenwald, P., Sondik, E., Lynch, B.S. 1986. Diet and chemoprevention in Nci’s research strategy to achieve national cancer control objectives. Annu. Rev. Public Health 7: 267–291.

    Article  PubMed  CAS  Google Scholar 

  2. Greenwald, P., Cullen, J.W., McKenna, J.W. 1987. Cancer prevention and control from research through applications. J. Natl. Cancer Inst. 79: 389–400.

    PubMed  CAS  Google Scholar 

  3. Bertram, J.S., Kolonel, L.N., Meyskens, Jr., F.L. 1987. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res. 47: 3012–3031.

    PubMed  CAS  Google Scholar 

  4. Malone, W.F., Kelloff, G.J., Boone, C., Nixon, D.W. 1989. Chemoprevention and modern cancer prevention. Prevent. Med. 18: 553–561.

    Article  CAS  Google Scholar 

  5. Greenwald, P., Nixon, D.W., Malone, W.F., Kelloff, G.J., Stern, H.R., Lit-Kin, K.M. 1990. Concepts in cancer chemoprevention research. Cancer 65: 1483–1490.

    Article  PubMed  CAS  Google Scholar 

  6. Costa, A., Santoro, G., Assimakopoulos, G. 1990. Cancer chemoprevention: A review of ongoing clinical trials. Acta Oncol. 29: 657–663.

    Article  PubMed  CAS  Google Scholar 

  7. Bjelke, E. 1975. Dietary vitamin A and human lung cancer. Int. J. Cancer 15: 561–565.

    Article  PubMed  CAS  Google Scholar 

  8. Shekelle, R.B., Liu, S., Raynor, Jr., W.J., Lepper, M., Makza, C., Rossof, A.H., Paul, O., Shryock, A.M., Stamiler, J. 1981. Dietary vitamin A and risk of cancer in the Western Electric study. Lancet 2: 1185–1189.

    Article  PubMed  CAS  Google Scholar 

  9. Hirayama, T. 1979. Diet and cancer. Nutr. Cancer 1: 67–81.

    Article  Google Scholar 

  10. Block, G. 1992. Vitamin C status and cancer. Epidemiologic evidence of reduced risk. Ann. N.Y. Acad. Sci. 669: 281–292.

    Article  Google Scholar 

  11. Hocman, G. 1992. Chemoprevention of cancer: Protease inhibitors. Int. J. Biochem. 24: 1365–1375.

    Article  PubMed  CAS  Google Scholar 

  12. Troll, W. 1989. Protease inhibitors interfere with the necessary factors of carcinogenesis. Environ. Health Perspect. 81: 59–62.

    Article  PubMed  CAS  Google Scholar 

  13. Knekt, P. 1992. Vitamin E and cancer: Epidemiology. Ann. N.Y. Acad. Sci. 669: 269–279.

    Article  PubMed  CAS  Google Scholar 

  14. Butterworth, Jr., C.E. 1992. Effect of folate on cervical cancer. Ann. N.Y. Acad. Sci. 669: 293–299.

    Article  PubMed  Google Scholar 

  15. Cordell, G.A., Pezzuto, J.M., Hamburger, M.O., Gunawardana, Y.A.G.R, Shieh, H.-L., McPherson, D.D. 1989. Recent studies on anticancer agents. In: Progress in Chemistry of Medicinal Plants in Asia. Proceedings of the Sixth Asian Symposium on Medicinal Plants and Spices. Bandung, Indonesia. pp 243-254.

    Google Scholar 

  16. Cordell, G.A., Farnsworth, N.R., Beecher, C.W.W., Soejarto, D.D., King-Horn, A.D., Pezzuto, J.M., Wall, M.E., Wani, M.C., Cobb, R.R., Harris, T.J.R., O’Neill, M.J., Tait, R.M. 1994. Novel strategies for the discovery of plant-derived anticancer agents. In: Second Symposium on Anticancer Drug Discovery and Development, Traverse City, Michigan, June 27–29, 1991. Kluwer Adademic Publishers, Boston. pp. 63–83.

    Google Scholar 

  17. Tan, G.T., Pezzuto, J.M., Kinghorn, A.D. 1992. Screening of natural products as HIV-1 and HIV-2 reverse transcriptase (RT) inhibitors. In: Natural Products as Antiviral Agents. (C.K. Chu, H. Cutler, eds.). Plenum Press, N.Y. pp 195–222.

    Chapter  Google Scholar 

  18. Cordell, G.A., Kinghorn, A.D., Pezzuto, J.M. 1993. Separation, structure elucidation and bioassay of cytotoxic natural products. In: Bioactive Natural Products: Detection, Isolation and Structural Identification. (S.M. Colegate, R.J. Molyneux, eds.). CRC Press, Boca Raton. pp 195–219.

    Google Scholar 

  19. Shamon, L., Pezzuto, J.M. 1994. Plant antimutagens: A review and strategy for the identification of therapeutically useful agents. In: Economic and Medicinal Plant Research. Vol. 6. (N.R. Farnsworth, H. Wagner, eds.). Academic Press, London. pp 235–297.

    Google Scholar 

  20. Angerhofer, C.K., König, G.M., Wright, A.D., Sticher, O., Milhous, W.K., Cordell, G.A., Farnsworth, N.R., Pezzuto, J.M. 1993. Selective screening of natural products: A resource for the discovery of novel antimalarial compounds. In: New Trends in Natural Products Chemistry. (Atta-ur-Rahman, ed.). pp 431–443.

    Google Scholar 

  21. Cordell, G.A., Farnsworth, N.R., Beecher, C.W.W., Soejarto, D.D., Kinghorn, A.D., Pezzuto, J.M., Wall, M.E., Wani, M.C., Brown, D.M., O’Neill, M.J., Lewis, J.A., Tait, R.M., Harris, T.J.R. 1993. Novel strategies for the discovery of plant-derived anticancer agents. In: Human Medicinal Agents from Plants (ACS Symposium Series No. 534). (A.D. Kinghorn, M.F. Balandrin, eds.) A.CS. Wash. D.C. pp 191–204.

    Chapter  Google Scholar 

  22. Pezzuto, J.M. 1993. Cancer chemopreventive agents: From plant materials to clinical intervention trials. In: Human Medicinal Agents from Plants (Acs Symposium Series No. 534). (A.D. Kinghorn, M.F. Balandrin, eds.). A.C.S. Wash. D.C. pp 205–217.

    Chapter  Google Scholar 

  23. Suffness, S.M., Pezzuto, J.M. 1991. Assays for cytotoxicity and antitumor activity. Chapter 4. In: Methods of Plant Biochemistry, Vol. 9. (K. Hostettmann ed.). Academic Press, London. pp 71–133.

    Google Scholar 

  24. Kinghorn, A.D., Balandrin, M.F. (eds.). 1993. Human Medicinal Agents from Plants (ACS Symposium Series No. 534). A.C.S. Wash. D.C pp 356.

    Google Scholar 

  25. Cordell, G.A., Beecher, C.W.W., Pezzuto, J.M. 1991. Can ethnopharmacology contribute to the development of new anticancer drugs? J. Ethnopharmacol. 32: 117–133.

    Article  PubMed  CAS  Google Scholar 

  26. Angerhofer, C.K., Pezzuto, J.M. 1993. Applications of biotechnology for drug discovery and evaluation. In: Biotechnology and Pharmacy. (J.M. Pezzuto, M.E. Johnson, H.R. Manasse, Jr., eds.). Chapman and Hall, N.Y. pp 312–365.

    Chapter  Google Scholar 

  27. Cassady, J.M., Baird, W.M., Chang, C-J. 1990. Natural products as a source of potential cancer chemotherapeutic and chemopreventive Agents. J. Nat. Prod. 53: 23–41.

    Article  PubMed  CAS  Google Scholar 

  28. Muto, Y., Ninomiya, M., Fujiki, H. 1990. Present status of research on cancer chemoprevention in Japan. Jpn. J. Clin. Oncol. 20: 219–224.

    PubMed  CAS  Google Scholar 

  29. Bertram, J.S., Hossain, M.Z., Pung, A, Rundhaug, J.E. 1989. Development of in vitro systems for chemoprevention research. Prev. Med. 18: 562–575.

    Article  PubMed  CAS  Google Scholar 

  30. Beecher, C.W.W., Farnsworth, N.R., Fong, H.H.S., Kinghorn, A.D., Mehta, R.G., Moon, R.C., Moriarty, R.M., Pezzuto, J.M., Soejarto, D.D., Wall, M.E., Wani, M. 1993. Identification and Characterization of Natural Inhibitors of Carcinogene-sis. Proc. Am. Assoc. Cancer Res. 34:559.

    Google Scholar 

  31. Shamon, L.A., Chen, C., Mehta, R.G., Steele, V., Moon, R.C., Pezzuto, J.M. A correlative approach for the discovery of antimutagens that demonstrate cancer chemopreventive activity. Anticancer Res. 14: in press.

    Google Scholar 

  32. Ip, C., Ganther, H. E. 1991. Combination of blocking agents and suppressing agents in cancer prevention. Carcinogenesis 12: 365–367.

    Article  PubMed  CAS  Google Scholar 

  33. Zhang, Y., Talalay, P., Cho, C.-G., Posner, G.H. 1992. A major inducer of anticarcinogenic protective enzymes from broccoli: Isolation and elucidation of structure. Proc. Natl. Acad. Sci. USA 89: 2399–2403.

    Article  PubMed  CAS  Google Scholar 

  34. Prochaska, H.J., Santamaria, A.B., Talalay, P. 1992. Rapid detection of in-ducers of enzymes that protect against carcinogens. Proc. Natl. Acad. Sci. Usa 89: 2394–2398.

    Article  PubMed  CAS  Google Scholar 

  35. De Long, M., Santamaria, A.B., Talalay, P. 1987. Role of cytochrome Pl-450 in the induction of NAD(P)H:quinone reductase in a murine hepatoma cell line and its mutants. Carcinogenesis 8: 1549–1553.

    Article  PubMed  Google Scholar 

  36. Miller, A.G., Israel, D., Whitlock, Jr., J.P. 1983. Biochemical and genetic analysis of variant mouse hepatoma cells defective in induction of benzo(a)pyrene-metabolizing enzyme activity. J. Biol. Chem. 258: 3523–3527.

    PubMed  CAS  Google Scholar 

  37. Takai, Y., Kikkawa, U., Kaibuchi, K., Nishizuka, Y. 1984. Membrane phospholipid metabolism and signal transduction for protein phosphorylation. Adv. Cyclic Nucleotide Prot. Phosphoryl. Res. 18: 119–158.

    CAS  Google Scholar 

  38. Nishizuka, Y. 1984. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693–698.

    Article  PubMed  CAS  Google Scholar 

  39. Castagna, M., Takai, Y, Kaibuchi, K., Sano, K., Kikkawa, U., Nishizuka, Y. 1982. Direct activation of calcium-activated phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 257: 7847–7851.

    PubMed  CAS  Google Scholar 

  40. Bell, R.M. 1986. Protein kinase C activation by diacylglycerol second messengers. Cell 45: 631–632.

    Article  PubMed  CAS  Google Scholar 

  41. Verma, A.K. 1988. The protein kinase C activator L-α-dioctanoylglycerol: A potent stage II mouse skin tumor promoter. Cancer Res. 48: 1736–1739.

    PubMed  CAS  Google Scholar 

  42. Cerutti, P.A. 1988. Oxidant tumor promoter. In: UCLA Symposia on Molecular and Cellular Biology New Series, Vol. 58, Growth Factors, Tumor Promoters, and Cancer Genes. (N.H. Colburn, H.L. Moses, E.J. Stanbridge, eds.). Alan R. Liss, Inc., N.Y. pp 239–247.

    Google Scholar 

  43. Lupulescu, A. 1978. Enhancement of carcinogenesis by Prostaglandins. Nature 272: 634–636.

    Article  PubMed  CAS  Google Scholar 

  44. Reddy, B.S. 1992. Inhibitors of the arachidonic acid cascade and their chemoprevention of colon carcinogenesis. In: Cancer Chemoprevention. (L. Wattenberg, M. Lipkin, C.W. Boone, G.L. Kelloff, eds.). CRC Press, Boca Raton. pp 153–164.

    Google Scholar 

  45. Verma, A.K., Ashendel, C.L., Boutwell, R.K. 1980. Inhibition by Prostaglandin synthesis inhibitors of the induction of epidermal Ornithine decarboxylase activity, the accumulation of Prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 40: 308–315.

    PubMed  CAS  Google Scholar 

  46. Collins, S.J. 1987. The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression. Blood 70: 1233–1244.

    PubMed  CAS  Google Scholar 

  47. Eismam, J.A., Koga, M., Sutherland, R.L., Barkla, D.H., Tutton, P.J.M. 1989. 1,25-Dihydroxyvitamin D3 and the regulation of human cancer cell replication. P.S.E.B.M. 191: 221–226.

    Google Scholar 

  48. Colston, K.W., Berger, U., Coombes, R.C. 1989. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet, January 28, 1989, pp 188-191.

    Google Scholar 

  49. Colston, K., Wilkinson, J.R., Coombes, R.C. 1986. 1,25-Dihydroxyvitamin D3 binding in estrogen-responsive rat breast tumor. Endocrinol. 119: 397–403.

    Article  CAS  Google Scholar 

  50. Han, X.L., Liehr, J.G. 1992. Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res. 52: 1360–1363.

    PubMed  CAS  Google Scholar 

  51. Smigel, K. 1992. Breast cancer prevention trial takes off. J. Natl. Cancer Inst. 84: 669–670.

    Article  PubMed  CAS  Google Scholar 

  52. Sasson, S., Notides, A.C. 1988. Mechanism of the estrogen receptor interaction with 4-hydroxytamoxifen. Mol. Endocrinol. 2: 307–312.

    Article  PubMed  CAS  Google Scholar 

  53. Geier, A., Beery, R., Haimsohn, M., Lunenfeld, B. 1987. Analysis of the 4-hydroxytamoxifen (4-Ohtam) bound nuclear estrogen receptor from MCF-7 cells by limited proteolysis. J. Steroid Biochem. 28: 471–478.

    Article  PubMed  CAS  Google Scholar 

  54. Metzger. D., Losson, R., Bornert, J.M., Lemoine, Y., Chambon, P. 1992. Promoter specificity of the two transcriptional activation functions of the human oestrogen receptor in yeast. Nucleic Acids Res. 20: 2813–2817.

    Article  PubMed  CAS  Google Scholar 

  55. Fawell, S.E., White, R., Hoare, S., Sydenham, M., Page, M., Parker, M.G. 1990. Inhibition of estrogen receptor-DNA binding by the “pure” antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc. Natl. Acad. Sci. USA 87: 6883–6887.

    Article  PubMed  CAS  Google Scholar 

  56. Antoniotti, S., Maggiora, P., Dati, C., Debortoli, M. 1992. Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitro. Eur. J. Cancer. 28: 318–321.

    Article  PubMed  CAS  Google Scholar 

  57. Lykkesfeldt, A.E., Sorensen, E.K. 1992. Effect of estrogen and antiestrogens on cell proliferation and synthesis of secreted proteins in the human breast cancer cell line MCF-7 and a tamoxifen resistant variant subline, AL-1. Acta Oncol. 31: 131–138.

    Article  PubMed  CAS  Google Scholar 

  58. Sutherland, R.L., Watts, C.K., Hall, R.E., Ruenitz, P.C. 1987. Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells. J. Steroid Biochem. 27: 891–897.

    Article  PubMed  CAS  Google Scholar 

  59. Littlefield, B.A., Gurpide, R., Markiewicz, L., Mckinley, B., Hochberg, R.B. 1990. A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline Phosphatase in Ishikawa cells: Estrogenic action of A 5 adrenal steroids. Endocrinol. 127: 2757–2762.

    Article  CAS  Google Scholar 

  60. Albert, J.L., Sundstrom, S.A., Lyttle, C.R. 1990. Estrogen regulation of placental alkaline Phosphatase gene expression in a human endometrial adenocarcinoma cell line. Cancer Res. 50: 3306–3310.

    PubMed  CAS  Google Scholar 

  61. Holinka, C.F., Hata, H., Kuramoto, H., Gurpide, E. 1986. Effects of steroid hormones and antisteroids on alkaline Phosphatase activity in human endometrial cancer cells (Ishikawa line). Cancer Res. 46: 2771–2774.

    PubMed  CAS  Google Scholar 

  62. Anon. 1982. Aromatase: New Perspectives for Breast Cancer. Cancer Res. (Suppl.) 42:3261s–3469s.

    Google Scholar 

  63. Coombes, R.C., Evans, T.R.J. 1991. Aromatase Inhibitors 2. In: The Medical Management of Breast Cancer. (T. Powles, I.E. Smith, eds.). Martin Dunitz, London, pp 81–93.

    Google Scholar 

  64. Wouters, W., De Coster, R., Krekels, M., Van Dun, J., Beererns, D., Haelterman, C., Raeymaekers, A., Freyne, E., Van Gelder, J., Venet, M., Janssen, Raj. 1989. R76713, Anew specific non-steroidal aromatase inhibitor. J. Steroid Biochem. 32: 781–788.

    Article  PubMed  CAS  Google Scholar 

  65. De Coster, R., Wouters, W., Bowden, C.R., Vanden Bossche, H., Bruyn-Seels, J., Tuman, R.W., Vanginckel, R., Snoeck, E., Van Peer, A., Janssen, P.A.J. 1990. New non-steroidal aromatase inhibitors: Focus on R76713. J. Steroid Biochem. Mol. Biol. 37: 335–341.

    Article  PubMed  Google Scholar 

  66. Mehta, R.G., Constantinou, A., Moriarty, R., Pezzuto, J.M., Moon, R.C. 1993. Brassinin: A novel chemopreventive agent. Proc. Am. Assoc. Cancer Res. 34: 127.

    Google Scholar 

  67. Mehta, R.G., Moriarty, R.M., Liu, J., Constantinou, A., Thomas, C., Hawthorne, M., You, M., Gerhäuser, C., Pezzuto, J.M., Moon, R.C. Synthesis and cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. Carcinogenesis, in press.

    Google Scholar 

  68. Mehta, R.G., Liu, J., Constantinou, A., Hawthorne, M., Pezzuto, J.M., Moon, R.C., Moriarty, R.M. Structure-activity relationships of brassinin in preventing the development of carcinogen-induced mammary lesions in mammary gland organ culture. Anticancer Res. 14: 1209–1213.

    Google Scholar 

  69. You, M., Gerhäuser, C., Liu, J., Moriarty, R.M., Mehta, R.G., Moon, R.C., Pezzuto, J.M. 1994. Induction of quinone reductase activity mediated by brassinin and its derivatives. Proc. Am. Assoc. Cancer Res. 35:627.

    Google Scholar 

  70. Ishii, R., Yoshikawa, K., Minakata, H., Komura, H., Kada, T. 1984. Specificity of bio-antimutagens in plant kingdom. Agr. Biol. Chem. 48: 2587–2591.

    Article  Google Scholar 

  71. Beecher, C.W.W., Pezzuto, J.M., Farnsworth, N.R. 1993. Meta-analysis of published literature as a means of chemopreventive drug discovery. Proc. Am. Assoc. Cancer Res. 34:127.

    Google Scholar 

  72. Kinghorn, A.D., Mehta, R.G., Moon, R.C., Pezzuto, J.M. 1993. Bioassay-directed isolation of natural inhibitors of carcinogenesis. Proc. Am. Assoc. Cancer Res. 34:558.

    Google Scholar 

  73. Herbert, J.M., Augereau, J.M., Gleye, J., Maffrand, J.P. 1990. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172: 993–999.

    Article  PubMed  CAS  Google Scholar 

  74. Luyengi, L., Lee, I.-S., Mar, W., Fong, H.H.S., Pezzuto, J.M., Kinghorn, A.D. Rotenoids and chalcones from Mundulea sericea that inhibit phorbol ester-induced Ornithine decarboxylase activity. Phytochemistry 36: 1523–1526.

    Google Scholar 

  75. Pezzuto, J.M., Mar, W., Luyengi, L., Kinghorn, A.D., Fong, H.H.S., Halline, A.G., Mehta, R.G., Moon, R.C. 1994. Rotenoid-mediated inhibition of Ornithine decarboxylase activity as a mechanism of chemopreventive activity. Proc. Am. Assoc. Cancer Res. 35:627.

    Google Scholar 

  76. Boone, C.W., Kelloff, G.J., Malone, W.E. 1990. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human intervention trials: A review. Cancer Res. 50: 2–9.

    PubMed  CAS  Google Scholar 

  77. Sporn, M.B., Squire, R.A., Brown, C.C., Smith, J.M., Wenk, M.L., Springer, S. 1977. 13-cis-Retinoic acid: Inhibition of bladder carcinogenesis in rats. Science 195: 487–489.

    Article  PubMed  CAS  Google Scholar 

  78. Moon, R.C., Grubbs, C.J., Sporn, M.B., Goodman, D.G. 1977. Retinyl acetate inhibits mammary carcinogenesis induced by N-methyl-N-nitrosourea. Nature 267: 620–621.

    Article  PubMed  CAS  Google Scholar 

  79. Sporn, M.B., Clamon, G.H., Dunlop, N.M., Newton, D.L., Smith, J.M., Saf-Fiotti, U. 1975. Activity of vitamin A analogs in cell cultures of mouse epidermis and organ culture of hamster trachea. Nature 253: 47–50.

    Article  PubMed  CAS  Google Scholar 

  80. Moon, R.C., Thompson, H.J., Becci, P.J., Grubbs, C.J., Gander, R.J., Newton, D.L., Smith, J.M., Phillips, S.L., Henderson, W.R., Mullen, L.T., Brown, C.C., Sporn, M.B. 1979. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in rat. Cancer Res. 39: 1339–1346.

    PubMed  CAS  Google Scholar 

  81. McCormick, D.L., Mehta, R.G., Thompson, C.A., Dinger, N., Caldwell, J.L., Moon, R.C. 1982. Enhanced inhibition of mammary carcinogenesis by combination of N-(4-hydroxyphenyl)retinamide and ovariectomy. Cancer Res. 42: 508–512.

    PubMed  CAS  Google Scholar 

  82. Moon, R.C., Mehta, R.G., Rao, K.V.N. 1993. Retinoids and cancer in experimental animals. In: The Retinoids: Biology, Chemistry and Medicine, Second edition. (M.B. Sporn, A.B. Roberts, D.S. Goodman, eds.). pp 573-592.

    Google Scholar 

  83. Malone, W. F. 1991. Studies evaluating antioxidants and β-carotene as chemopreventives. Am. J. Clin. Nutr. 53:305S–313S.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Pezzuto, J.M. (1995). Natural Product Cancer Chemopreventive Agents. In: Arnason, J.T., Mata, R., Romeo, J.T. (eds) Phytochemistry of Medicinal Plants. Recent Advances in Phytochemistry, vol 29. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1778-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-1778-2_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-1780-5

  • Online ISBN: 978-1-4899-1778-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics